File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/1471-244X-14-138
- Scopus: eid_2-s2.0-84901234926
- PMID: 24885177
- WOS: WOS:000336064300001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator
Title | The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator |
---|---|
Authors | |
Keywords | Cognition Faux pas Eyes test Theory of mind Schizophrenia Emotion |
Issue Date | 2014 |
Publisher | BioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmcpsychiatr/ |
Citation | BMC Psychiatry, 2014, v. 14, article no. 138 How to Cite? |
Abstract | BACKGROUND: The relationship between neurocognition and symptomatology in people with schizophrenia has been established. The present study examined whether social cognition could mediate this relationship. METHODS: There were 119 participants (58 people with paranoid schizophrenia and 61 healthy controls) participated in this study. Neurocognition was assessed by Raven's Progressive Matrices Test, the Judgment of Line Orientation Test, and the Tower of London Test. Psychiatric symptoms in people with schizophrenia were assessed by the Positive and Negative Syndrome Scale. Social cognition was measured by the Faux Pas Test, the 'Reading the Mind in the Eyes' Test, and the Interpersonal Reactivity Index. RESULTS: Results were consistent with previous findings that neurocognition and social cognition were impaired in the clinical participants. A novel observation is that social cognition significantly mediated the relationship between neurocognition and symptomatology. CONCLUSIONS: These findings suggest that neurocognitive deficits predispose people with schizophrenia to worse psychiatric symptoms through the impairment of social cognition. Findings of the present study provide important insight into a functional model of schizophrenia that could guide the development of cost-effective interventions for people with schizophrenia. |
Persistent Identifier | http://hdl.handle.net/10722/198658 |
ISSN | 2023 Impact Factor: 3.4 2023 SCImago Journal Rankings: 1.301 |
PubMed Central ID | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lam, BYH | en_US |
dc.contributor.author | Raine, A | en_US |
dc.contributor.author | Lee, TMC | en_US |
dc.date.accessioned | 2014-07-07T08:35:06Z | - |
dc.date.available | 2014-07-07T08:35:06Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.citation | BMC Psychiatry, 2014, v. 14, article no. 138 | en_US |
dc.identifier.issn | 1471-244X | - |
dc.identifier.uri | http://hdl.handle.net/10722/198658 | - |
dc.description.abstract | BACKGROUND: The relationship between neurocognition and symptomatology in people with schizophrenia has been established. The present study examined whether social cognition could mediate this relationship. METHODS: There were 119 participants (58 people with paranoid schizophrenia and 61 healthy controls) participated in this study. Neurocognition was assessed by Raven's Progressive Matrices Test, the Judgment of Line Orientation Test, and the Tower of London Test. Psychiatric symptoms in people with schizophrenia were assessed by the Positive and Negative Syndrome Scale. Social cognition was measured by the Faux Pas Test, the 'Reading the Mind in the Eyes' Test, and the Interpersonal Reactivity Index. RESULTS: Results were consistent with previous findings that neurocognition and social cognition were impaired in the clinical participants. A novel observation is that social cognition significantly mediated the relationship between neurocognition and symptomatology. CONCLUSIONS: These findings suggest that neurocognitive deficits predispose people with schizophrenia to worse psychiatric symptoms through the impairment of social cognition. Findings of the present study provide important insight into a functional model of schizophrenia that could guide the development of cost-effective interventions for people with schizophrenia. | - |
dc.language | eng | en_US |
dc.publisher | BioMed Central Ltd. The Journal's web site is located at http://www.biomedcentral.com/bmcpsychiatr/ | - |
dc.relation.ispartof | BMC Psychiatry | en_US |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Cognition | - |
dc.subject | Faux pas | - |
dc.subject | Eyes test | - |
dc.subject | Theory of mind | - |
dc.subject | Schizophrenia | - |
dc.subject | Emotion | - |
dc.title | The relationship between neurocognition and symptomatology in people with schizophrenia: social cognition as the mediator | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lee, TMC: tmclee@hku.hk | en_US |
dc.identifier.authority | Lee, TMC=rp00564 | en_US |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1186/1471-244X-14-138 | en_US |
dc.identifier.pmid | 24885177 | - |
dc.identifier.pmcid | PMC4026589 | - |
dc.identifier.scopus | eid_2-s2.0-84901234926 | - |
dc.identifier.hkuros | 229819 | en_US |
dc.identifier.hkuros | 229820 | - |
dc.identifier.volume | 14 | en_US |
dc.identifier.spage | article no. 138 | - |
dc.identifier.epage | article no. 138 | - |
dc.identifier.isi | WOS:000336064300001 | - |
dc.publisher.place | United Kingdom | - |
dc.customcontrol.immutable | sml 141205 | - |
dc.identifier.issnl | 1471-244X | - |